Hantz Financial Services Inc. grew its position in shares of The Cooper Companies, Inc. (NASDAQ:COO – Free Report) by 240.5% during the 3rd quarter, HoldingsChannel.com reports. The firm owned 15,621 shares of the medical device company’s stock after buying an additional 11,033 shares during the quarter. Hantz Financial Services Inc.’s holdings in Cooper Companies were worth $883,000 as of its most recent filing with the SEC.
Other hedge funds also recently made changes to their positions in the company. Avalon Trust Co acquired a new stake in shares of Cooper Companies during the second quarter worth about $25,000. Jacobi Capital Management LLC acquired a new stake in shares of Cooper Companies in the 3rd quarter valued at about $25,000. Elevation Wealth Partners LLC boosted its position in shares of Cooper Companies by 1,136.4% in the 2nd quarter. Elevation Wealth Partners LLC now owns 408 shares of the medical device company’s stock valued at $29,000 after purchasing an additional 375 shares during the period. Continuum Advisory LLC acquired a new stake in shares of Cooper Companies in the 2nd quarter valued at about $30,000. Finally, J.Safra Asset Management Corp purchased a new position in Cooper Companies during the 2nd quarter worth approximately $32,000. Hedge funds and other institutional investors own 24.39% of the company’s stock.
Insider Buying and Selling at Cooper Companies
In related news, Director Paul Keel acquired 4,701 shares of the firm’s stock in a transaction on Friday, September 11th. The stock was bought at an average cost of $53.18 per share, with a total value of $249,999.18. Following the transaction, the director owned 4,701 shares of the company’s stock, valued at $249,999.18. The trade was a ? increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Walter Rosebrough, Jr. bought 3,000 shares of the stock in a transaction on Monday, September 14th. The stock was bought at an average price of $54.29 per share, for a total transaction of $162,870.00. Following the completion of the purchase, the director directly owned 20,000 shares in the company, valued at approximately $1,085,800. The trade was a 17.65% increase in their position. The SEC filing for this purchase provides additional information. Insiders purchased a total of 34,701 shares of company stock valued at $1,880,039 in the last ninety days. Insiders own 2.08% of the company’s stock.
Cooper Companies Price Performance
Shares of NASDAQ:COO opened at $60.33 on Friday. The company has a 50-day simple moving average of $58.26 and a 200-day simple moving average of $67.75. The Cooper Companies, Inc. has a one year low of $51.01 and a one year high of $89.83. The company has a debt-to-equity ratio of 0.23, a quick ratio of 0.73 and a current ratio of 1.22. The stock has a market capitalization of $11.47 billion, a price-to-earnings ratio of 20.59, a PEG ratio of 2.38 and a beta of 0.83.
Cooper Companies (NASDAQ:COO – Get Free Report) last released its quarterly earnings results on Wednesday, September 9th. The medical device company reported $1.15 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.12 by $0.03. Cooper Companies had a return on equity of 10.90% and a net margin of 13.46%. The firm had revenue of $1.07 billion for the quarter, compared to analyst estimates of $1.10 billion. During the same quarter last year, the company posted $0.49 earnings per share. The business’s revenue was up .5% on a year-over-year basis. Cooper Companies has set its Q4 2026 guidance at 1.050-1.090 EPS and its FY 2026 guidance at 4.510-4.550 EPS. On average, analysts predict that The Cooper Companies, Inc. will post 4.53 EPS for the current year.
Cooper Companies announced that its Board of Directors has authorized a stock buyback program on Wednesday, September 9th that authorizes the company to repurchase $3 billion in shares. This buyback authorization authorizes the medical device company to buy up to 22.7% of its shares through open market purchases. Share buyback programs are usually a sign that the company’s management believes its shares are undervalued.
Wall Street Analyst Weigh In
Several research analysts have commented on the company. Barclays raised Cooper Companies to a “hold” rating in a research report on Wednesday, October 7th. Needham & Company LLC decreased their price objective on Cooper Companies from $86.00 to $73.00 and set a “buy” rating for the company in a report on Thursday, September 10th. Wells Fargo & Company set a $61.00 price objective on Cooper Companies and gave the company an “equal weight” rating in a report on Thursday, September 10th. Weiss Ratings lowered shares of Cooper Companies from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Wednesday, October 28th. Finally, Stifel Nicolaus set a $70.00 target price on shares of Cooper Companies and gave the company a “buy” rating in a report on Thursday, September 10th. Four equities research analysts have rated the stock with a Buy rating, twelve have issued a Hold rating and three have assigned a Sell rating to the company. According to data from MarketBeat.com, Cooper Companies presently has a consensus rating of “Hold” and a consensus target price of $68.60.
Cooper Companies Profile
CooperCompanies is a global medical device company focused on vision care and women’s health. It serves customers in markets around the world through two primary businesses: CooperVision and CooperSurgical. CooperVision develops and sells contact lenses, including products for daily wear, astigmatism, presbyopia and myopia management. Its offerings include lenses made from silicone hydrogel and other materials, as well as specialty lens options. CooperSurgical provides products and services for women’s health and fertility care.
Further Reading
- Five stocks we like better than Cooper Companies
- Grand Theft Auto VI Arrives: Why Take-Two Is a Waiting Game
- Greg Abel Makes His Next Moves: Inside Berkshire’s Q3 Portfolio
- Walmart Earnings Change the Narrative as Digital Growth Lifts Outlook
- Whatever Happens to Copper Next, These 3 Investments Offer Different Ways to Play It
Want to see what other hedge funds are holding COO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Cooper Companies, Inc. (NASDAQ:COO – Free Report).
Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.
